http://lifestyle.lmcordoba.com.ar/

Author: Neomorph, Inc.

Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting

April 28, 2026
Neomorph Announces Closing of $100 Million Series B Financing

April 28, 2026
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

February 3, 2026